A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys

Logan College of Chiropractic

Status and phase: Completed; Phase 2

Conditions: Primary Insomnia

Treatments: Device: Microcurrent

Study type: Interventional

Funder types: Other

Identifiers

NCT00520832

SR0524070091

Details and patient eligibility

About

Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia.

The hypothesis is that the experimental group will have significantly improved scores on three sleep surveys after treatment while the sham group will not.

Enrollment: 20 estimated patients

Sex: All

Ages: 18 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Student, Faculty or Staff
• Age 18 - 40
• Symptoms of primary insomnia

Exclusion criteria

• No implanted electric devices
• No local infection, injury or malignancy
• No history of seizure or other neurological disorders
• No current use of prescription or other substances that could effect sleep quality or quantity
• Pregnancy

Trial design

20 participants in 2 patient groups, including a placebo group

MC-E

Experimental group

Description:

20 minutes of sub-threshold microcurrent 2 hours before bedtime per day for 21 days.

Treatment:

Device: Microcurrent

Device: Microcurrent

MC-P

Placebo Comparator group

Description:

Participants will receive a device identical to the active device used in the experimental condition, but which produces no current.

Treatment:

Device: Microcurrent

Device: Microcurrent